Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Videocapillaroscopic Findings in Hand Osteoarthritis

11 november 2026 uppdaterad av: Nurten NAS KIRDAR, Bandırma Onyedi Eylül University

Association of Nailfold Videocapillaroscopy Findings With Clinical, Functional, and Radiological Characteristics in Primary Hand Osteoarthritis: A Comparative Cross-Sectional Study With Healthy Controls

The purpose of this study is to compare microvascular changes-assessed via nailfold videocapillaroscopy-in patients with primary hand osteoarthritis against a healthy control group, and to investigate the relationship between capillaroscopic findings and disease severity, functional status, and clinical characteristics.

Studieöversikt

Status

Har inte rekryterat ännu

Detaljerad beskrivning

In this context, the associations between capillaroscopic parameters and the Kellgren-Lawrence radiological grading, handgrip strength, the Functional Index for Hand Osteoarthritis (FIHOA), and the Australian/Canadian Osteoarthritis Hand Index (AUSCAN) scores will be evaluated. Furthermore, the study aims to determine the potential clinical value of nailfold videocapillaroscopy in identifying microvascular alterations associated with primary hand osteoarthritis.

Studietyp

Observationell

Inskrivning (Beräknad)

130

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studera Kontakt Backup

  • Namn: Ayşegül ÖZDOĞAN BİRCAN, Specialist Physician

Studieorter

    • Balıkesir
      • Bandırma, Balıkesir, Turkiet (Türkiye), 10200
        • Bandırma Onyedi Eylul University Faculty of Medicine
        • Kontakt:
        • Kontakt:

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Ja

Kön som är behöriga för studier

Allt

Testmetod

Sannolikhetsprov

Studera befolkning

The study population will consist of patients diagnosed with primary hand osteoarthritis and age- and sex-matched healthy controls. Participants will undergo clinical assessment, hand function evaluation, radiographic assessment, and nailfold videocapillaroscopy.

Beskrivning

Inclusion Criteria:

  • Patient group (Primary hand osteoarthritis)

    • Being 18 years of age or older.
    • Having a diagnosis of primary hand osteoarthritis in accordance with the 2018 EULAR recommendations.
    • Being willing to participate in the study and having signed the written Informed Consent Form.
    • Being able to undergo clinical assessment, nailfold videocapillaroscopy, and the necessary functional evaluations.
    • Having hand radiographs of sufficient quality to be evaluated according to the Kellgren-Lawrence classification system.

Healthy control group

  • Being 18 years of age or older.
  • Having no diagnosis of inflammatory rheumatologic disease or primary hand osteoarthritis.
  • Being willing to participate in the study and having signed the written Informed Consent Form.
  • Being similar to the patient group in terms of age and gender.
  • Being able to undergo nailfold videocapillaroscopy assessment.

Exclusion Criteria:

  • Patient group

    • Being under 18 years of age.
    • Diagnosis of secondary osteoarthritis of the hand (due to trauma, infection, metabolic, or other causes).
    • Presence of rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, systemic sclerosis, Sjögren's syndrome, inflammatory myopathies, vasculitis, or other connective tissue diseases.
    • History of Raynaud's phenomenon.
    • History of malignancy.
    • Chronic renal failure (stage 4-5) or advanced liver failure.
    • Active infection or a serious infection within the last four weeks.
    • Pregnancy or breastfeeding.
    • History of a neurological condition that could affect hand grip strength (e.g., hemiplegia, tetraplegia, peripheral nerve injury, or other neurological/neuromuscular disorders resulting in loss of muscle strength).
    • History of trauma, surgical intervention, or any procedure affecting the nail bed of the fingers within the last month.
    • Presence of an open wound, active infection, severe dermatological condition, or deformity that would hinder the assessment of the nail fold.
    • Refusal to participate in the study or failure to sign the informed consent form.

Healthy control group

In addition to the exclusion criteria listed above:

  • Diagnosis of primary osteoarthritis of the hand or any inflammatory rheumatic disease.
  • Presence of hand pain or any chronic musculoskeletal disorder that affects hand function.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Observationsmodeller: CASE_CONTROL
  • Tidsperspektiv: CROSS_SECTIONAL

Kohorter och interventioner

Grupp / Kohort
hand osteoarthritis group

hand osteoarthritis group;

  • Being 18 years of age or older.
  • Having a diagnosis of primary hand osteoarthritis in accordance with the 2018 EULAR recommendations.
  • Being willing to participate in the study and having signed the written Informed Consent Form.
  • Being capable of undergoing clinical assessment, nailfold videocapillaroscopy, and the necessary functional evaluations.
  • Having hand radiographs of sufficient quality to be evaluated according to the Kellgren-Lawrence classification system.
control group

control group;

  • Being 18 years of age or older.
  • Absence of a diagnosis of inflammatory rheumatic disease or primary osteoarthritis of the hand.
  • Willingness to participate in the study and having signed the written Informed Consent Form.
  • Having characteristics similar to the patient group in terms of age and gender.
  • Being able to undergo the nailfold videocapillaroscopy assessment.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Nailfold videocapillaroscopic microvascular parameters
Tidsram: 6 months

The primary outcome is the comparison of nailfold videocapillaroscopic microvascular parameters between patients with primary hand osteoarthritis and healthy controls.

Nailfold videocapillaroscopy will be performed using the Dino-Lite Capillary Scope Pro200 digital microscope and DinoCapture v2.0 software. Prior to the examination, participants will be required to rest for at least 15 minutes in a room maintained at a constant temperature of 20-22°C; they will also be instructed to refrain from smoking or consuming caffeine for at least 30 minutes before the procedure. Participants will be questioned regarding any recent manicures, nail-biting, local trauma, or other procedures that might affect the nail bed. During the examination, the hands will be kept at the level of the heart, and immersion oil will be applied to the nailfold. The second through fifth digits of both hands will be evaluated at ×200 magnification, and images of two 1 mm areas from each digit will be recorded.

6 months

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Kellgren-Lawrence classification
Tidsram: 6 months

Participants' hand radiographs will be evaluated for signs of osteoarthritis. The presence of osteophytes, joint space narrowing, subchondral sclerosis, cystic changes, and deformities in the distal interphalangeal, proximal interphalangeal, and first carpometacarpal joints will be recorded. The radiological severity of the disease will be graded from 0 to 4 for each joint using the Kellgren-Lawrence classification: grade 0, no radiological evidence of osteoarthritis; grade 1, questionable joint space narrowing and possible osteophytes; grade 2, definite osteophytes and possible joint space narrowing; grade 3, multiple osteophytes, definite joint space narrowing, sclerosis, and possible bone contour deformity; and grade 4, severe joint space loss, large osteophytes, marked sclerosis, and bone deformity. Radiographic hand osteoarthritis will be defined, in general, as a Kellgren-Lawrence grade of ≥2.

6 months
Australian/Canadian Osteoarthritis Hand Index (AUSCAN)
Tidsram: 6 months

Disease-related pain, stiffness, and functional impairment will be assessed using the Australian/Canadian Osteoarthritis Hand Index (AUSCAN). AUSCAN is a 15-item, patient-reported outcome measure developed for hand osteoarthritis, comprising subscales for pain (5 items), morning stiffness (1 item), and physical function (9 items). The function subscale evaluates difficulty with activities of daily living, such as turning on a faucet, operating a doorknob, buttoning clothes, opening a jar, carrying heavy objects, and grasping small items. The scale can be administered using Likert, visual analog, or numerical rating formats; the specific version and scoring method to be used in this study will be standardized in advance. Higher scores indicate more severe symptoms and greater loss of function.

6 months
Functional Index for Hand Osteoarthritis (FIHOA/Dreiser Index)
Tidsram: 6 months

Functional impairment due to hand osteoarthritis will also be assessed using the Functional Index for Hand Osteoarthritis (FIHOA/Dreiser Index). The FIHOA is a 10-item scale that evaluates daily hand functions, such as using a key, cutting with a knife, opening a bottle or jar, buttoning, writing, lifting objects, and shaking hands. Each item is scored on a scale of 0-3, with a total score ranging from 0-30; a higher score indicates greater functional impairment. The validity and reliability of the Turkish version of the FIHOA have been established, and it has been reported to demonstrate high internal consistency and test-retest reliability.

6 months
Handgrip strength
Tidsram: 6 months

Grip strength will be measured separately for each hand using a standard hand dynamometer (Baseline brand, 200 lb LITE hydraulic hand dynamometer). During the measurement, the participant will be in a seated position, with the shoulder in adduction and neutral rotation, the elbow flexed at approximately 90°, the forearm in a neutral position, and the wrist in slight extension. Three measurements will be taken for each hand, with short rest intervals between them; the analysis will utilize either the mean of these measurements or the highest value, in accordance with a pre-established protocol. The brand and model of the dynamometer used will be specified in the research form. Grip strength measurements obtained via a hand dynamometer have been shown to be reliable in patients with hand osteoarthritis.

6 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Nurten NAS KIRDAR, Bandırma Onyedi Eylül University

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

20 november 2026

Primärt slutförande (Beräknad)

20 april 2027

Avslutad studie (Beräknad)

30 april 2027

Studieregistreringsdatum

Först inskickad

11 november 2026

Först inskickad som uppfyllde QC-kriterierna

11 november 2026

Första postat (Faktisk)

17 november 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

17 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

11 november 2026

Senast verifierad

1 november 2026

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • E-67961857-050.04-2600065387

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

IPD-planbeskrivning

Individual participant data (IPD) will not be shared with other researchers due to patient confidentiality and data privacy considerations. Only anonymized aggregate data may be reported in the publication.

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera